Co.'s 'Monster' Earnings Surpass Analyst's Forecast
Source: Noel Atkinson  (8/11/22)
Big earnings results posted by Data Communications Management Corp. have led an analyst to raise his target and estimates for the company. More >

Copper Update and a Promising Copper Stock
Source: Clive Maund  (8/11/22)
Expert Clive Maund reviews the latest updates in copper stocks and how he thinks this turnaround will effect copper company Infinitum Copper. More >

Expert Says, 'Royalties Have Advantage During Price Inflation'
Source: Adrian Day   (8/11/22)
More resource companies released quarterly earnings, but since in all cases production and other items had been pre-released, there were few surprises for expert Adrian Day. More >

Canadian Marketing Co. Pivots From Print to Digital
Source: Streetwise Reports  (8/10/22)
One of Canada’s largest printing and marketing services company is growing its coffers by expanding its digital footprint. More >

Testing Confirms Drug Candidate Differs From Peers
Source: Dr. Douglas Loe  (8/10/22)
Biotech ProMIS Neurosciences Inc.'s monoclonal antibody in development for Alzheimer's disease boasts a "unique" binding profile that could be "important to its clinical success," noted a Leede Jones Gable report. More >

Expert Rates Digital Printing Co. An Immediate Speculative Buy
Source: Clive Maund  (8/10/22)
Expert Clive Maund reviews the most recent updates from digital printing company Data Communications Management Corp. to tell you whether or not he believes it is a Buy. More >

Demand for Co.’s Antibiotic Free Animal Feed Is Raising
Source: Clive Maund  (8/10/22)
With consumers moving away from artificial meat products and other preservatives, Avivagen Inc.'s antibiotic free animal feed seems to be just what they're looking for. With orders coming in and demand raising, expert Clive Maund shares his view on the potential of this life science company. More >

Green Energy Co. Bringing Its Hydrogen Boilers to Australia
Source: Streetwise Reports  (8/10/22)
Jericho Energy Ventures Inc.'s hydrogen boiler technology creates high-temperature water and steam with no greenhouse gases. The only by-product is water. More >

Why These Two Analysts Are Following Emerita
Source: Streetwise Reports  (8/10/22)
The latest data from Emerita Resources Corp. may support growth of the company's overall project resource, noted a Clarus Securities report. More >

Pharma Co. Achieves Record Sales of LEMS Drug in Q2
  (8/10/22)
Shares of Catalyst Pharmaceuticals Inc. traded 24% higher to a new 52-week high after the company reported that in Q2/22 net product revenues from sales of its FIRDAPSE® increased 57.7% YoY to $53.0 million. FIRDAPSE® has been approved by both the U.S. FDA and Health Canada as a treatment for adult patients with Lambert-Eaton myasthenic syndrome, a rare autoimmune disease in which a person's immune system attacks its body's own tissues at the neuromuscular junction. More >

Drone Focused Co. Positioned to Turn Profitable in FY23
Source: Dr. Ashok Kumar  (8/9/22)
Aided by the burgeoning drone industry, this company is expected to grow its revenue enough in the next 12 months to move into the black, noted a ThinkEquity report. More >

Major Uptrending Starting With Droneshield Ltd.
Source: Clive Maund  (8/9/22)
Expert Clive Maund reviews the most recent updates with tech co. DroneShield Ltd., a company he believes is at the start of a major uptrend. More >

Cardiovascular Device Co. On Pace to Double Revenue in FY22
Source: Streetwise Reports  (8/9/22)
Shares of Shockwave Medical Inc. traded 17% higher to a new 52-week high after the company advised that it posted a 116% YoY increase in revenue during Q2/22 and raised the midpoint for its FY/22 revenue guidance by $25 million to $465-475 million. More >

Junior Not Wasting Time While Waiting for Permits
Source: Streetwise Reports  (8/8/22)
This junior explorer is analyzing samples, conducting fieldwork and geophysical surveys, and mapping its British Columbia site with drones. But it can’t wait to drill and find out what’s underneath. More >

Agnico Has Strong Quarter: Production Up, Costs Down
Source: Adrian Day  (8/8/22)
Expert Adrian Day reviews recent quarterlies and other developments at some more of his favorite gold and silver companies.
More >

Offshore Oil Driller Boosts Output to 3.9 MMBoe in Q2
Source: Streetwise Reports  (8/8/22)
W&T Offshore Inc.'s shares traded 17% higher after the oil and gas producer reported Q2/22 financial results featuring a 106% YoY increase in revenue. The company noted it has been successful in increasing its proven reserves, reducing net debt levels, and is continuing to focus on generating free cash flow for shareholders. More >

Lithium Co. Starts Trading on the CSE in Reverse Takeover
  (8/8/22)
First Lithium Minerals Corp. will begin trading on the Canadian Stock Exchange tomorrow, August 9, 2022, under the symbol FLM, following the completion of a reverse takeover of both First Lithium Minerals Inc. and QL Minerals Inc. by First Lithium Minerals Corp. (formerly PetroCorp Group Inc.)
More >

Bear Market Rally Ending Soon
Source: Ron Struthers  (8/8/22)
A look at recent economic and market indicators that allude to more stagflation and not the outlook mainstream analysts are expecting. In other news, Greenbriar Capital Corp. is negotiating the purchase of a real estate franchise network to compliment its Sage Ranch 995 unit housing development. More >

Analyst Says Anti-Drone Co. On ‘Verge of Inflection Point’
Source: Streetwise Reports  (8/7/22)
Governments all over the world are more concerned than ever about the growing risk from drones that can carry weapons, engage in chemical warfare, and disrupt flights. One Australian company is using technology to mitigate the threat — without ever firing a bullet. More >

Biotech Co. Awakes To Good News
Source: Clive Maund  (8/6/22)
Awakn Life Sciences Corp.'s rating went to an Immediate Speculative Buy after it received substantial funding from the UK government. Expert Clive Maund shares his thoughts on the development. More >

Biopharma Co. Planning BLA for DMD Drug
Source: Yun Zhong, Ph.D.  (8/5/22)
Sarepta Therapeutics Inc. recently announced that it intends to submit a BLA to the U.S. FDA for its SRP-9001, a gene therapy to treat Duchenne muscular dystrophy. Equity research firm BTIG LLC advised in a research update that SRP-9001 seems to have met the necessary criteria for receiving accelerated approval and it expects an AdCom will be established shortly. BTIG stated that it rates Sarepta Therapeutics as a "Buy" and has a $125 price target for the company's shares. More >

SRT Device Maker's Revenues Rise 124% in Q2
Source: Streetwise Reports  (8/5/22)
Sensus Healthcare Inc.'s shares traded 30% higher after the company reported it achieved a 124% YoY increase in revenue in Q2/22. The company advised that demand continues to remain strong for its superficial radiation therapy (SRT) devices which provide minimally invasive and non-surgical alternatives for non-melanoma skin cancer & keloid removal. More >

Global Equities Offer Yields up to 8%
Source: Adrian Day  (8/5/22)
Expert Adrian Day reviews results and developments from some of his favorite non-resource companies. He believes all three are solid dividend payers, and for investors seeking income attractive buys. More >

Environmental Tech Co. Builds up to a Major Bull Market
Source: Clive Maund  (8/4/22)
After a few weeks of observation, expert Clive Maund believes Bion Environmental Technologies Inc. may be due for a major uptrend and is building up to a major bull market. More >

Seabridge Expands KSM Project to Copper-Rich Deposits
Source: Streetwise Reports  (8/4/22)
This junior releases a preliminary economic assessment focusing on new copper-rich deposits on its massive KSM site in the Golden Triangle. More >